Sacituzumab govitecan (IMMU-132) is an anti-human Trop-2 antibody-drug conjugate (ADC) for targeting delivery of the toxin component SN-38. Sacituzumab govitecan shows anticancer activity. It has a molecular weight of 160KDa. The DAR is n = 7.6. This product is for research use only.
Product Details |
Species Reactivity | Human |
---|
Type | Antibody-drug conjugate |
---|
ADC antibody | Sacituzumab (anti-Trop-2) |
---|
ADC cytotoxin (drug) | SN38 |
---|
Immunogen | Human Trop-2 |
---|
DAR (Drug to Antibody Ratio) | 7.6 |
---|
Purity | 98% |
---|
Molecular Weight | 160kDa |
---|
Protein Concentration | 10mg/ml |
---|
Storage Condition | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
---|
Storage Buffer | PBS buffer pH7.4 |